Metamark Genetics' Grant

Metamark Genetics raised a round of funding on February 17, 2012. Investors include Massachusetts Life Sciences Center.

Metamark Genetics is a privately-held biotechnology company founded to develop novel, function-based prognostic and diagnostic tests aimed at improving urological cancer care. Metamark is a provider o…

Articles about Metamark Genetics' Grant: